AtriCure (ATRC) Total Non-Current Liabilities (2010 - 2026)
AtriCure's (ATRC) quarterly Total Non-Current Liabilities came in at $153.0 million in Q2 2026, up 6.83% year-over-year from $143.2 million in Q2 2025, and up 5.51% quarter-over-quarter from $145.0 million in Q1 2026.
Analysis
AtriCure (ATRC) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has reported Total Non-Current Liabilities for 17 consecutive years, with $153.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 6.83% year-over-year to $153.0 million in Q2 2026; TTM through Jun 2026 was $153.0 million, a 6.83% increase from a year earlier, with the FY2025 full-year figure at $154.9 million, up 5.27% from the prior year.
- Total Non-Current Liabilities was $153.0 million for Q2 2026 at AtriCure, up from $145.0 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $154.9 million in Q4 2025 and troughed at $120.9 million in Q1 2022.
- A 5-year average of $138.7 million and a median of $136.0 million in 2023 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities declined 2.2% in 2022 and advanced 14.95% in 2023, its largest moves.
- Over 5 years, Total Non-Current Liabilities stood at $127.5 million in 2022, then climbed by 14.95% to $146.5 million in 2023, then grew by 0.42% to $147.1 million in 2024, then climbed by 5.27% to $154.9 million in 2025, then decreased by 1.25% to $153.0 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $153.0 million (Q2 2026), $145.0 million (Q1 2026), and $154.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.44 Bn |
| 10 | AtriCure | 2.58 Bn | 2.41 Bn | 118.63 Mn | 152.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 152.96 Mn |
| Mar 31, 2026 | 144.98 Mn |
| Dec 31, 2025 | 154.90 Mn |
| Sep 30, 2025 | 151.57 Mn |
| Jun 30, 2025 | 143.19 Mn |
| Mar 31, 2025 | 135.79 Mn |
| Dec 31, 2024 | 147.15 Mn |
| Sep 30, 2024 | 148.84 Mn |
| Jun 30, 2024 | 134.00 Mn |
| Mar 31, 2024 | 134.07 Mn |
| Dec 31, 2023 | 146.53 Mn |
| Sep 30, 2023 | 136.21 Mn |
| Jun 30, 2023 | 130.53 Mn |
| Mar 31, 2023 | 127.02 Mn |
| Dec 31, 2022 | 127.47 Mn |
| Sep 30, 2022 | 130.38 Mn |
| Jun 30, 2022 | 129.46 Mn |
| Mar 31, 2022 | 120.93 Mn |
| Dec 31, 2021 | 130.34 Mn |
| Sep 30, 2021 | 122.22 Mn |